BMS-986488
- Generic Name
- BMS-986488
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Phase 1
Recruiting
- Conditions
- Advanced Malignant Tumors
- Interventions
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 437
- Registration Number
- NCT06764771
- Locations
- 🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸Local Institution - 0020, Allentown, Pennsylvania, United States
🇺🇸The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath